Synopsis
Synopsis
0
KDMF
0
FDA Orange Book
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Antiminth
2. Combantrin
3. Embonate, Pyrantel
4. Embovin
5. Pamoate, Pyrantel
6. Pyrantel Embonate
1. 22204-24-6
2. Pyrantel Embonate
3. Antiminth
4. Combantrin
5. Pyrantel (pamoate)
6. Cp-10,423-16
7. Pyrantel (as Pamoate)
8. Embovin
9. (e)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1)
10. Nsc-355080
11. Chebi:8655
12. Cp 10423-16
13. 81bk194z5m
14. Nsc355080
15. (e)-1-methyl-2-(2-(thiophen-2-yl)vinyl)-1,4,5,6-tetrahydropyrimidine 4,4'-methylenebis(3-hydroxy-2-naphthoate)
16. Cp-10423-16
17. Cp-10423-18
18. Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)ethenyl)-, (e)-, Compd. With 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic Acid) (1:1)
19. Cobantril
20. Sentry Hc Worm X
21. 2-naphthalenecarboxylic Acid, 4,4'-methylenebis[3-hydroxy-, Compd. With 1,4,5,6-tetrahydro-1-methyl-2-[(1e)-2-(2-thienyl)ethenyl]pyrimidine (1:1)
22. 4-[(3-carboxy-2-hydroxy-1-naphthyl)methyl]-3-hydroxy-naphthalene-2-carboxylic Acid; 1-methyl-2-[(e)-2-(2-thienyl)vinyl]-5,6-dihydro-4h-pyrimidine
23. 4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic Acid;1-methyl-2-[(e)-2-thiophen-2-ylethenyl]-5,6-dihydro-4h-pyrimidine
24. Sentry Hc Worm X Ds
25. Einecs 244-837-1
26. Vetscription Sure Shot 2x
27. Nsc 355080
28. Pyirantelpamoate
29. Unii-81bk194z5m
30. Pyrantel Pamoates
31. Pyranteli Embonas
32. Antiminth (tn)
33. Pyrantel Pamoate [usan:usp:jan]
34. 2-naphthalenecarboxylic Acid, 4,4'-methylenebis(3-hydroxy-, Compd. With 1,4,5,6-tetrahydro-1-methyl-2-((1e)-2-(2-thienyl)ethenyl)pyrimidine (1:1)
35. Spectrum5_001373
36. Pyrantel Pamoate, Bioxtra
37. (3-hydroxy-2-naphthoate)
38. Schembl41025
39. 2-naphthalenecarboxylic Acid, 4,4'-methylenebis(3-hydroxy-, Compd. With (e)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)ethenyl)pyrimidine (1:1)
40. Pyrantel Pamoate [mi]
41. Spectrum1500517
42. Pyrantel Pamoate [jan]
43. Pyrantel Pamoate (jp17/usp)
44. Schembl7793068
45. Pyrantel Pamoate [usan]
46. Chembl1599768
47. Pyrantel Pamoate [vandf]
48. Hms500m16
49. Pyrantel Pamoate Sigmaultra,(s)
50. Amy3564
51. Dtxsid40897057
52. Pyrantel Embonate [mart.]
53. Pyrantel Pamoate [usp-rs]
54. Hms1920n06
55. Hms2090j21
56. Hms2092e07
57. Pharmakon1600-01500517
58. Pyrantel Embonate [who-dd]
59. Pyrantel Embonate [who-ip]
60. Ccg-39242
61. Mfcd00072037
62. Nsc757303
63. S2501
64. Stl481883
65. Pyrantel Pamoate [green Book]
66. Akos015908224
67. Cs-3869
68. Nsc-757303
69. Idi1_000254
70. Pyrantel Embonate [ep Monograph]
71. Pyrantel Pamoate [usp Monograph]
72. Ncgc00094552-01
73. Ncgc00094552-02
74. Ncgc00094552-03
75. Pyranteli Embonas [who-ip Latin]
76. 2-naphthoic Acid, 4,4'-methylenebis(3-hydroxy-, Compd. With (e)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine (1:1)
77. 4,4'-methylenebis(3-hydroxy-2-naphthoic) Acid, Compound With (e)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine (1:1)
78. Ac-24204
79. As-12185
80. Bp166202
81. Hy-12640
82. Sbi-0051499.p003
83. C07389
84. D00486
85. F21340
86. 204p246
87. A816013
88. Sr-05000001708
89. Q3489331
90. Sr-05000001708-1
91. Pyrantel Pamoate, Vetranal(tm), Analytical Standard
92. (e)-1-methyl-2-(2-(thiophen-2-yl)vinyl)-1,4,5,6
93. Pyrantel Embonate, European Pharmacopoeia (ep) Reference Standard
94. Pyrantel Pamoate, United States Pharmacopeia (usp) Reference Standard
95. Pyrimidine,1,4,5,6-tetrahydro-1-methyl-2-[(1e)-2-(2-thienyl)ethenyl]-
96. (e)-1,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidine 4,4'-methylenebis[3-hydroxy-2-naphthoate] (1:1)
97. 2-naphthalenecarboxylic Acid,4'-methylenebis[3-hydroxy-, Compd. With (e)-1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)ethenyl]pyrimidine (1:1)
98. 2-naphthoic Acid,4'-methylenebis[3-hydroxy-, Compd. With (e)-1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidine (1:1)
99. 4,4'-methanediylbis(3-hydroxynaphthalene-2-carboxylic Acid) - 1-methyl-2-[(e)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine (1:1)
100. 4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic Acid,1-methyl-2-[(e)-2-thiophen-2-ylethenyl]-5,6-dihydro-4h-pyrimidine
101. Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-[2-(-2-thienyl)ethenyl-, (e)-, With 4,4'-methylenebis[3-hydroxy-2-naphthalenecarboxylic Acid (1:1)
Molecular Weight | 594.7 g/mol |
---|---|
Molecular Formula | C34H30N2O6S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 6 |
Exact Mass | 594.18245785 g/mol |
Monoisotopic Mass | 594.18245785 g/mol |
Topological Polar Surface Area | 159 Ų |
Heavy Atom Count | 43 |
Formal Charge | 0 |
Complexity | 816 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antinematodal Agents
Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
44
PharmaCompass offers a list of Pyrantel Pamoate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pyrantel Pamoate manufacturer or Pyrantel Pamoate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pyrantel Pamoate manufacturer or Pyrantel Pamoate supplier.
PharmaCompass also assists you with knowing the Pyrantel Pamoate API Price utilized in the formulation of products. Pyrantel Pamoate API Price is not always fixed or binding as the Pyrantel Pamoate Price is obtained through a variety of data sources. The Pyrantel Pamoate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Combantrin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Combantrin, including repackagers and relabelers. The FDA regulates Combantrin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Combantrin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Combantrin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Combantrin supplier is an individual or a company that provides Combantrin active pharmaceutical ingredient (API) or Combantrin finished formulations upon request. The Combantrin suppliers may include Combantrin API manufacturers, exporters, distributors and traders.
click here to find a list of Combantrin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Combantrin DMF (Drug Master File) is a document detailing the whole manufacturing process of Combantrin active pharmaceutical ingredient (API) in detail. Different forms of Combantrin DMFs exist exist since differing nations have different regulations, such as Combantrin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Combantrin DMF submitted to regulatory agencies in the US is known as a USDMF. Combantrin USDMF includes data on Combantrin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Combantrin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Combantrin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Combantrin Drug Master File in Japan (Combantrin JDMF) empowers Combantrin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Combantrin JDMF during the approval evaluation for pharmaceutical products. At the time of Combantrin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Combantrin suppliers with JDMF on PharmaCompass.
A Combantrin CEP of the European Pharmacopoeia monograph is often referred to as a Combantrin Certificate of Suitability (COS). The purpose of a Combantrin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Combantrin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Combantrin to their clients by showing that a Combantrin CEP has been issued for it. The manufacturer submits a Combantrin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Combantrin CEP holder for the record. Additionally, the data presented in the Combantrin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Combantrin DMF.
A Combantrin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Combantrin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Combantrin suppliers with CEP (COS) on PharmaCompass.
A Combantrin written confirmation (Combantrin WC) is an official document issued by a regulatory agency to a Combantrin manufacturer, verifying that the manufacturing facility of a Combantrin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Combantrin APIs or Combantrin finished pharmaceutical products to another nation, regulatory agencies frequently require a Combantrin WC (written confirmation) as part of the regulatory process.
click here to find a list of Combantrin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Combantrin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Combantrin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Combantrin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Combantrin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Combantrin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Combantrin suppliers with NDC on PharmaCompass.
Combantrin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Combantrin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Combantrin GMP manufacturer or Combantrin GMP API supplier for your needs.
A Combantrin CoA (Certificate of Analysis) is a formal document that attests to Combantrin's compliance with Combantrin specifications and serves as a tool for batch-level quality control.
Combantrin CoA mostly includes findings from lab analyses of a specific batch. For each Combantrin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Combantrin may be tested according to a variety of international standards, such as European Pharmacopoeia (Combantrin EP), Combantrin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Combantrin USP).